Core Viewpoint - Ying Sheng Science (00209.HK) has announced the results of its rights issue, indicating a strong level of acceptance and additional applications for shares [1] Group 1: Rights Issue Acceptance - The company received 9 valid acceptance notices for a total of 810,881,342 shares, representing approximately 62.38% of the total 1,299,962,832 shares available for subscription [1] - Additionally, the company received 3 valid applications for extra shares amounting to 228,089,351 shares, which is about 17.54% of the total shares available for subscription [1] - In total, there were 12 valid acceptances and applications for 1,038,970,693 shares, accounting for approximately 79.92% of the total shares available for subscription [1]

Group 1 - The company, Ying Sheng Science (00209), announced that as of January 8, 2026, a total of 1.039 billion shares were validly accepted and applied for in the rights issue, representing approximately 79.92% of the total 1.3 billion shares available for subscription [1] - Due to insufficient subscriptions, approximately 261 million shares were not subscribed, accounting for about 20.08% of the total shares available for subscription [1] - Following the underwriting agreement, the underwriters facilitated the subscription of the 261 million shares, resulting in the total shares available for subscription being fully subscribed [1] Group 2 - The total amount raised from the rights issue is approximately HKD 182 million, with the estimated net proceeds after deducting underwriting commissions and other related expenses being around HKD 176.5 million [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示不會就本公告全部或任何部份內容而產 生或因依賴該等內容而引致之任何損失承擔任何責任。 本公告僅供參考，並不構成收購、購買或認購本公司任何證券之邀請或要約。 WINSHINE SCIENCE COMPANY LIMITED 209 按於記錄日期 每持有一(1)股現有股份獲發七(7)股供股股份的基準 以悉數包銷方式進行供股的結果 茲提述瀛晟科學有限公司（「本公司」）日期為二零二五年十二月二十二日內容有關供股之 供股章程（「供股章程」）。除文義另有所指外，本公告所用詞彙與供股章程所定義者具有 相同涵義。 供股結果 董事會欣然宣佈，於二零二六年一月八日（星期四）下午四時正（即接納供股股份及繳付股 款以及申請額外供股股份及繳付股款的最後時限）： 合共12份有關1,038,970,693股供股股份的有效接納及申請已獲接納及申請，佔供股項下可 供認購的1,299,962,832股供股股份總數約79.92%。 因此，供股出現認購不足，260,992,139股供股股份未獲認購，佔供股項下可供認購的 1,299 ...

Core Viewpoint - The article discusses the recent stock transfer of Ying Sheng Science (00209) and its proposed rights issue to raise capital [1] Group 1: Stock Transfer - On January 7, shareholders of Ying Sheng Science transferred shares from lmagi Brokerage Limited to Futu Securities International Hong Kong, with a transfer value of HKD 1.9689 million, representing 5.96% of the company [1] Group 2: Rights Issue - Ying Sheng Science announced a proposal for a rights issue, offering 7 new shares for every existing share held at a subscription price of HKD 0.14 per share [1] - The company aims to issue up to approximately 1.3 billion rights shares, assuming no changes in the number of shares issued as of the record date, to raise a total of approximately HKD 182 million [1]

Core Viewpoint - The article highlights the recent stock transfer of Ying Sheng Science (00209) from lmagi Brokerage Limited to Futu Securities International Hong Kong, along with the company's proposed rights issue to raise capital [1] Group 1: Stock Transfer - On January 7, Ying Sheng Science's shareholder transferred stocks valued at HKD 1.9689 million, representing 5.96% of the total shares [1] Group 2: Rights Issue - Ying Sheng Science announced a rights issue proposal, offering 7 new shares for every existing share held at a subscription price of HKD 0.14 per share [1] - The company aims to issue up to approximately 1.3 billion new shares, assuming no changes in the number of shares issued by the record date, to raise a total of approximately HKD 182 million [1]

公司名稱: 瀛晟科學有限公司 (於百慕達註冊成立之有限公司) FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年12月31日 狀態: 新提交 致：香港交易及結算所有限公司 呈交日期: 2026年1月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00209 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | 70,000,000,000 | HKD | | 0.01 | HKD | | 700,000,000 | | 增加 / 減少 (-) | | | 0 | | | HKD | | 0 | | 本月底結存 | | 70,000,000,000 | HKD | | 0.01 | HKD | | 700,000,000 | ...

茲提述本公司日期為二零二五年六月三十日之公告及日期為二零二五年九月三十日之公 告（「九月公告」），內容有關更新本公司為改善本集團的流動資金及財務狀況所採取的計 劃及措施，以解決持續經營問題。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示不會就本公告全部或任何部份內容而產 生或因依賴該等內容而引致之任何損失承擔任何責任。 WINSHINE SCIENCE COMPANY LIMITED 209 有關截至二零二四年十二月三十一日止年度之年報 所載就持續經營不發表意見之季度更新 本公告乃由瀛晟科學有限公司（「本公司」，連同其附屬公司統稱「本集團」）董事會（「董事 會」或「董事」）作出，旨在知會本公司股東及潛在投資者有關本公司於二零二五年四月三 十日所刊發截至二零二四年十二月三十一日止年度之年報（「年報」）所載就持續經營不發 表意見（「不發表意見」）之最新進展。除文義另有所指外，本公告所用詞彙與年報所定義 者具有相同涵義。 王敬渝 香港，二零二五年十二月三十一日 於本公告日期，董事會由下列董事組成： 自九月公告刊發起直至本公告日期，本公司已進 ...

Core Viewpoint - The Hong Kong stock market has shown significant gains, with several companies experiencing substantial increases in their stock prices, indicating a positive market sentiment and potential investment opportunities. Group 1: Stock Performance - Shinyeh Holdings (06038.HK) has seen a remarkable increase of 32.81% [1][2] - Elephant Holdings Group (08635.HK) has risen by 28.09% [1][2] - Tongyuan International (03830.HK) has gained 25.00% [1][2] - Weiye Holdings (01570.HK) has increased by 23.40% [1][2] - Baiaosaitu-B (02315.HK) has experienced a rise of 22.23% [1][2] - Dongyao Pharmaceutical-B (01875.HK) has grown by 19.05% [1][2] - Xinneng Low Carbon (00145.HK) has increased by 17.78% [1][2] - China Shangcheng (02330.HK) has seen a rise of 17.71% [1][2] - Yingsheng Science (00209.HK) has gained 16.89% [1][2] - Base Champion Group (08460.HK) has increased by 16.82% [1][2]

WINSHINE SCIENCE COMPANY LIMITED 瀛晟科學有限公司* （於百慕達註冊成立的有限公司） （股份代號：209） 各位非登記股東1： 瀛晟科學有限公司(「本公司」) - 於本公司網站登載公司通訊之通知 A. 於本公司網站登載公司通訊之通知 此通知 閣下，本公司之下述公司通訊2 (「本次公司通訊」)之英文及中文版本現已登載於本公司網站 www.winshine.com（「本公司網站」）及香港聯合交易所有限公司（「聯交所」）網站www.hkexnews.hk（「聯交所網 站」）以供閱覽： 請於本公司網站「投資者關係」一欄或聯交所網站內讀取本次公司通訊。若 閣下早前曾要求收取公司通訊的印刷本， 本次公司通訊的印刷本已隨函附上。 B. 透過電子方式向非登記股東發佈日後公司通訊 本公司透過電子方式向其非登記股東發佈日後公司通訊。請注意，所有公司通訊的英文及中文版本將在本公司網站 www.winshine.com和聯交所網站www.hkexnews.hk上提供（「網站版本」）。除非 閣下提出要求，公司不會向 閣下郵寄 公司通訊的印刷本。 本公司透過電子郵件方式或郵寄方式（僅於代 閣下持有股份的銀 ...

WINSHINE SCIENCE COMPANY LIMITED 瀛晟科學有限公司* （於百慕達註冊成立的有限公司） （股份代號：209） 各位登記股東： 於本公司網站登載公司通訊之通知 謹此通知 閣下，瀛晟科學有限公司（「本公司」）之下述公司通訊1（「本次公司通訊」）之英文及中文版本，現已登載於 本公司網站www.winshine.com（「本公司網站」）及香港聯合交易所有限公司（「聯交所」）網站www.hkexnews.hk（「聯 交所網站」）以供閱覽： 請於本公司網站「投資者關係」一欄或聯交所網站內讀取本次公司通訊。若 閣下早前曾要求收取公司通訊的印刷本，本次 公司通訊的印刷本已隨函附上。 為了支援通過電郵進行電子通訊，本公司建議 閣下向本公司香港股份過戶登記分處卓佳證券登記有限公司（「香港股份過 戶登記分處」）（地址為香港夏慤道16號遠東金融中心17樓）發出（不少於七天的）合理書面通知，或發送電郵至 is-ecom@vistra.com向本公司提供 閣下的電郵地址。 股東有責任提供有效的電郵地址。若本公司沒有股東的電郵地址或 閣下提供的電郵地址無效，本公司將透過郵寄方式向 閣下發送 (i) 於本公司網 ...